Buy today and pay later: Afterpay and zippay available at checkout.

0

Your Cart is Empty

Conditions covered:
Expanded panel
267 recessive and 21 X-linked (only females tested) conditions.

Comprehensive panel
521 recessive and 35 X-linked (only females tested) conditions

Sample type:
Saliva

Ideal timeframe:
Pre-pregnancy or in first trimester

Genetic counselling:
Genetic counselling is included for every patient with before, during and after hour secure video consultation.

Genetic education:
Carefully curated pre-test videos and resources to help fully inform your patient about screening.

Price:
Expanded panel (up to 289 genes)
$795 for an individual
$995 for a couple

Comprehensive panel (up to 556 genes)
$995 for an individual
$1195 for a couple

Turn around time:
3-6 weeks

Lab results:
Internationally accredited, medically actionable.

Methodology:
Full-gene sequencing and deletion / duplication analysis using next-generation sequencing technology.

Meet the team

Genetics experts

About the test panel

A testing panel of up to 556 serious and actionable conditions.

We use an Invitae panel that includes up to 556 autosomal recessive and X-linked conditions, including Cystic Fibrosis, Spinal Muscular Atrophy, Fragile X syndrome, Thalassemia, and Tay-Sachs disease. These conditions are serious, actionable and relevant for patients to know about.

Eugene's non-invasive tests in action

A simple process direct to your patients

Why carrier testing?

An increasingly routine practice in preconception and prenatal care.

Everyone wants a healthy baby. Offering carrier screening to every patient, regardless of their ethnicity, age or family history, means better surveillance for more serious conditions. Knowing any risks in advance can help your patients make more informed reproductive choices; and if necessary, significantly reduce the risk of passing on a disease.

With both the RACGP and RANZCOG recommending that providers offer carrier screening to their patients who are family planning, the impetus to inform patients about carrier screening has never been greater.